Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Michele Wilson"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 879-886 (2024)
Objectives The 13-valent (PCV13) and 10-valent (PCV10) pneumococcal conjugate vaccines missed non-inferiority for certain 7-valent (PCV7) serotypes in immunogenicity trials. This study examines the population-level IPD case trends for these serotypes
Externí odkaz:
https://doaj.org/article/b2af8fd431f24efa983b229a2a481989
Autor:
Michele Wilson, Cheryl McDade, Anna Trisia Beby-Heijtel, Angela Waterval-Overbeek, Vishalini Sundaram, Johnna Perdrizet
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 7, Pp 1809-1821 (2023)
Abstract Introduction The 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix) was introduced into the Dutch pediatric national immunization program (NIP) starting in 2011. However, there is substantial pneumococcal disease burden due to incre
Externí odkaz:
https://doaj.org/article/e4f2250be4154cf89e7baf3d8ac9eb14
Autor:
Johnna Perdrizet, Emily K. Horn, Kyla Hayford, Lindsay Grant, Rachid Barry, Liping Huang, Cheryl McDade, Michele Wilson
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 5, Pp 1351-1364 (2023)
Abstract Introduction This study estimates the annual population-level impact of 13-valent pneumococcal conjugate vaccine (PCV13) infant national immunization programs (NIPs) on vaccine-type and non-vaccine type invasive pneumococcal disease (IPD) in
Externí odkaz:
https://doaj.org/article/a02a168a132041509e51588b17b29c26
Autor:
Michele Wilson, Aaron Lucas, Diana Mendes, Andrew Vyse, Boglarka Mikudina, Carole Czudek, Gillian Frances Ellsbury, Johnna Perdrizet
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1168 (2023)
Currently, the 13-valent pneumococcal conjugate vaccine (PCV13) is administered under a 1+1 (1 primary dose) pediatric schedule in the United Kingdom (UK). Higher-valency PCVs, 15-valent PCV (PCV15), or 20-valent PCV (PCV20) might be considered to ex
Externí odkaz:
https://doaj.org/article/964eebe835f94664b09127ed965e5863
Autor:
Matthew Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, F. Berenice Baez/Revueltas, Michele Wilson, Cheryl McDade, Raymond Farkouh
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 560-569 (2019)
Introduction: Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccines (PCV13) since thei
Externí odkaz:
https://doaj.org/article/bce77725061b4dd3b159e912c6f0891b
Autor:
Matt Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, Michele Wilson, Cheryl McDade, Raymond Farkouh
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 572-574 (2019)
In a recent Letter, Gomez et. al. provided a critique of our original analysis estimating the clinical and economic impact of switching from the 13-valent (PCV13) to the 10-valent (PCV10) pneumococcal conjugate vaccine in Mexico. This comment address
Externí odkaz:
https://doaj.org/article/c772fdf8f00f4af3af77445a95ab1e52
Autor:
Michele Wilson, Benjamin Gutierrez, Steve J Offord, Christopher M Blanchette, Anna Eramo, Stephanie Earnshaw, Siddhesh A Kamat
Publikováno v:
Drugs in Context, Pp 1-10 (2016)
Background: Schizophrenia is associated with high direct healthcare costs due to progression of disease and frequent occurrence of relapses. Aripiprazole once-monthly (AOM) has been shown to reduce total psychiatric hospitalizations among patients wh
Externí odkaz:
https://doaj.org/article/3029300f7a7a4bd4a664fbe9af199c17
Autor:
Perdrizet, Michele Wilson, Aaron Lucas, Diana Mendes, Andrew Vyse, Boglarka Mikudina, Carole Czudek, Gillian Frances Ellsbury, Johnna
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1168
Currently, the 13-valent pneumococcal conjugate vaccine (PCV13) is administered under a 1+1 (1 primary dose) pediatric schedule in the United Kingdom (UK). Higher-valency PCVs, 15-valent PCV (PCV15), or 20-valent PCV (PCV20) might be considered to ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::2c32c2fbc746252b99d83f6041e0bcc8
Autor:
Raymond Farkouh, Annick Mignon, Cheryl McDade, Johnna Perdrizet, Michele Wilson, Matt Wasserman
Publikováno v:
Infectious Diseases and Therapy
Introduction Since 2010, 10-valent (PCV10) and 13-valent pneumococcal conjugate vaccines (PCV13) have been available as part of infant national immunization programs. Belgium is as one of the few countries that implemented PCV13 (2007–2015), switch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb8280d2af808968f8fbc2034c2dc64
https://doi.org/10.1007/s40121-021-00485-9
https://doi.org/10.1007/s40121-021-00485-9
Autor:
Marquita Decker-Palmer, Chia-Wei Lin, Michele Wilson, Cheryl McDade, Komal Bawa, Stacey Kowal, Arliene Ravelo, Elaine Yu, Richard H. Ko
Publikováno v:
Blood. 140:13041-13042
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87279510a921cc3dad0529a71b124330
https://doi.org/10.1182/blood-2022-162276
https://doi.org/10.1182/blood-2022-162276